| Literature DB >> 20881040 |
Edwin R Manuel1, Wendy W Yeh, Harikrishnan Balachandran, Ryon H Clarke, Michelle A Lifton, Norman L Letvin.
Abstract
It has been suggested that vaccination prior to infection may direct the mutational evolution of human immunodeficiency virus type 1 (HIV-1) to a less fit virus, resulting in an attenuated course of disease. The present study was initiated to explore whether prior immunization might prevent the reversion of the virus to the wild-type form. Mamu-A*01 monkeys were vaccinated to generate a cytotoxic T-lymphocyte response to the immunodominant Gag p11C epitope and were then challenged with a cloned pathogenic CXCR4-tropic simian-human immunodeficiency virus (SHIV) expressing a mutant Gag p11C sequence (Δp11C SHIV). The epitopic and extraepitopic compensatory mutations introduced into gag of Δp11C SHIV resulted in attenuated replicative capacity and eventual reversions to the wild-type Gag p11C sequence in naïve rhesus monkeys. However, in vaccinated rhesus monkeys, no reversions of the challenge virus were observed, an effect that may have been a consequence of significantly decreased viral replication rather than a redirection of the mutational evolution of the virus. These findings highlight the multifactorial pressures that affect the evolution of primate immunodeficiency viruses.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20881040 PMCID: PMC3004339 DOI: 10.1128/JVI.01193-10
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103